- Home
- BKTI vs FENC Comparison
BKTI vs FENC Comparison
Compare BKTI & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BKTI | FENC |
|---|---|---|
| Founded | 1997 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 277.9M | 266.4M |
| IPO Year | 2000 | 2010 |
Fundamental Metrics
Financial Performance| Metric | BKTI | FENC |
|---|---|---|
| Price | $95.58 | $6.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $74.00 | $15.00 |
| AVG Volume (30 Days) | 66.4K | ★ 220.5K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 52.89 | N/A |
| EPS | ★ 3.44 | N/A |
| Revenue | ★ $74,094,000.00 | $44,642,000.00 |
| Revenue This Year | $6.57 | $65.12 |
| Revenue Next Year | $15.00 | $41.08 |
| P/E Ratio | $27.70 | ★ N/A |
| Revenue Growth | ★ 45.42 | N/A |
| 52 Week Low | $36.17 | $5.02 |
| 52 Week High | $98.36 | $9.92 |
Technical Indicators
Market Signals| Indicator | BKTI | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 66.29 | 43.23 |
| Support Level | $73.21 | $5.65 |
| Resistance Level | N/A | $8.09 |
| Average True Range (ATR) | 4.88 | 0.38 |
| MACD | 1.94 | 0.06 |
| Stochastic Oscillator | 92.16 | 64.89 |
Price Performance
Historical ComparisonAbout BKTI BK Technologies Corporation
BK Technologies Corp is a holding company that, through BK Technologies, Inc., its operating subsidiary, provides public safety-grade communications products and services designed to make first responders safer and more efficient. All operating activities described herein are undertaken by its operating subsidiary. The Company has one reportable segment - Land Mobile Radio (LMR) Products and Solutions. The LMR segment provides radio devices that are hand-held (portable) or installed in vehicles (mobile) and operate on private radio systems that are P25 compliant. The Company derives revenue in North America and manages the business activities on a consolidated basis.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.